Mohammed Eslam

Research interests

Publications

• Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

  ˜The œLancet. Gastroenterology & hepatology · 2023 · https://doi.org/10.1016/s2468-1253(23)00141-3

• An international multidisciplinary consensus statement on MAFLD and the risk of CVD

  Hepatology International · 2023 · https://doi.org/10.1007/s12072-023-10543-8

• Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals

  The Journal of Clinical Endocrinology & Metabolism · 2022 · https://doi.org/10.1210/clinem/dgac321

• Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

  Gut · 2021 · https://doi.org/10.1136/gutjnl-2020-322564

• MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

  Gastroenterology · 2020 · https://doi.org/10.1053/j.gastro.2019.11.312

• A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.03.039

• The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

  Hepatology International · 2020 · https://doi.org/10.1007/s12072-020-10094-2

• Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

  Hepatology · 2019 · https://doi.org/10.1002/hep.30908

• Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

  ˜The œLancet. Gastroenterology & hepatology · 2019 · https://doi.org/10.1016/s2468-1253(19)30342-5

• The changing epidemiology of liver diseases in the Asia–Pacific region

  Nature Reviews Gastroenterology & Hepatology · 2018 · https://doi.org/10.1038/s41575-018-0055-0

• Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

  Gastroenterology · 2018 · 10.1053/j.gastro.2018.04.034

• Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

  Nature Reviews Gastroenterology & Hepatology · 2017 · 10.1038/nrgastro.2017.109

• Genetics and epigenetics of NAFLD and NASH: Clinical impact

  Journal of Hepatology · 2017 · https://doi.org/10.1016/j.jhep.2017.09.003

Current projects

No projects listed.